Bayer Gains as Judge Limits Evidence in Roundup Cancer Cases

Bookmark
(Bloomberg) -- Bayer AG shares rose after a judge issued a ruling that could limit evidence plaintiffs are permitted to present in cases alleging their cancers were caused by its Roundup weedkiller.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.